SCHEMBL30029189

SCHEMBL30029189

Cn1nc(Br)c2cccc(N)c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 2/20 0.47
▸ CRBN Q96SW2 2/20 0.47
▸ ALDH1A1 P00352 5/20 0.38
▸ HPGD P15428 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ TSHR P16473 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ MEN1 O00255 5/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ USP2 O75604 4/20 0.34
▸ KEAP1 Q14145 2/20 0.34
▸ ATM Q13315 1/20 0.34
▸ NFE2L2 Q16236 1/20 0.34
▸ MAPT P10636 4/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ RGS12 O14924 2/20 0.34
▸ RECQL P46063 2/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24754835 1.00 DDB1 (0.47) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL30848071 0.88 DDB1 (0.38) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL28237818 0.79 DDB1 (0.48) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL16722620 0.78 SSTR4 (0.39) ALDH1A1CYP3A4LMNATP53THRB
SCHEMBL27138457 0.78 DDB1 (0.47) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL30847906 0.78 DDB1 (0.47) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL27143123 0.78 DDB1 (0.47) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL7572100 0.75 MEN1 (0.37) MEN1KMT2AUSP2KEAP1NFE2L2
SCHEMBL30848080 0.75 DDB1 (0.45) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL27153773 0.75 DDB1 (0.45) DDB1CRBNALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
WO-2022266248-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2022-12-22 — — WO disclosed
Send feedback